Skip to main content
. 2020 Jan 20;10:643. doi: 10.1038/s41598-019-57218-9

Figure 2.

Figure 2

RNA expressions of gene signatures associated with therapeutic response and improved outcome to anti-PD-1. (a) The expression of M1 signature is significantly higher in DCB group compared to NDB group (t-test, P = 4.95e−4). (b) Patients with high M1 signature have significantly prolonged progression-free survival than those with low M1 signature (log-rank, P = 7.84 e−4). (c) Patients with high M1 signature have similar overall survival than those with low M1 signature (log-rank, P = 0.348). (d) The expression of peripheral T cell signature was significantly higher in DCB group compared to NDB group (t-test, P = 1.08e−4). (e) High peripheral T cell signature was associated with significantly prolonged progression-free survival (log-rank, P = 8.29e−3). (f) Patients with high peripheral T cell signature have similar overall survival than those with low signature (log-rank, P = 0.695).